Panel: People Over 75, Essential Workers Next for Vaccines
NEW YORK (AP) — A federal advisory panel recommended Sunday that people 75 and older and essential workers like firefighters, teachers and grocery store workers should be next in line for COVID-19 shots, while a second vaccine began rolling out to hospitals as the nation works to get the coronavirus pandemic under control.
The two developments came amid a vaccination program that began only in the last week and has given initial shots to about 556,000 Americans, according to the Centers for Disease Control and Prevention.
The COVID-19 vaccine developed by Pfizer Inc. and Germany’s BioNTech already is being distributed, and regulators last week gave approval to the one from Moderna Inc. that began shipping Sunday.
Earlier this month, the Advisory Committee on Immunization Practices said health care workers and nursing home residents — about 24 million people — should be at the very front of the line for the vaccines.
Sunday’s vote by the panel was who should be next in line, and by a vote of 13-1, it decided that it should be people 75 and older, who number about 20 million, as well as certain front-line workers, who total about 30 million.
The essential workers include firefighters and police; teachers and school staff; those working in food, agricultural and manufacturing sectors; corrections workers; U.S. Postal Service employees; public transit workers; and grocery store workers. They are considered at very high risk of infection because their jobs are critical and require them to be in regular contact with other people.
It’s not clear how long it will take to vaccinate those groups. Vaccine doses have come out slower than earlier projections. But at the same time, some experts noted that not everyone who is recommended to get vaccinated may choose to get a shot.
The committee also voted that behind those groups should be people aged 65 to 74, numbering about 30 million; those aged 16 to 64 with medical conditions like obesity and cancer who are at higher risk if they get COVID-19, numbering as many as 110 million; and a tier of other essential workers. This group of as many as 57 million includes a wide category of food service and utility workers but also those in legal and financial jobs and the media.
The expert panel’s recommendation next goes to the CDC director and to states as guidance to put together vaccination programs. CDC directors have almost always signed off on committee recommendations. No matter what the CDC says, there will be differences from state to state, because various health departments have different ideas about who should be closer to the front of the line.
Federal officials expect that vaccine doses will be limited for several months. CDC officials say up to 20 million are projected to start getting shots this month, another 30 million next month, and 50 million in February. That’s 100 million out of a population of more than 330 million.
Pfizer’s shots were first shipped out a week ago and started being used the next day, kicking off the nation’s biggest vaccination drive.
Public health experts say the shots — and others in the pipeline — are the only way to stop a virus that has been spreading wildly. Nationwide, more than 219,000 people per day on average test positive for the virus, which has killed over 316,000 in the U.S. and nearly 1.7 million worldwide.
Earlier Sunday, trucks left the Olive Branch, Mississippi, factory, near Memphis, Tennessee, with the vaccine developed by Moderna and the National Institutes of Health. The much-needed shots are expected to be given starting Monday, just three days after the Food and Drug Administration authorized their emergency rollout.
In Louisville, Kentucky, UPS driver Todd Elble said his vaccine shipment was the “most important load that I’ve hauled” in a 37-year career. His parents contracted COVID-19 in November, and his 78-year-old father died. He said the family speculates that his father got infected while traveling on a hunting trip with four other relatives to Wyoming, and some are still sick.
“I’m going to take the vaccine myself. I’m going to be first in line for my father — I’ll tell you that much — and any others that should follow,” he said. “I feel in my heart that everybody should, to help get this stopped.”
He added: “To bring this back, I feel Dad was in the truck with me today.”
Dr. Moncef Slaoui, the chief science adviser to the federal government’s vaccine distribution effort, said on CNN’s “State of the Union” that nearly 8 million doses will be distributed Monday, about 5.9 million of the Moderna vaccine and 2 million of the Pfizer vaccine.
Slaoui also predicted the U.S. will experience “a continuing surge,” with larger numbers of coronavirus cases possible from gatherings for Christmas.
“I think, unfortunately, it will get worse,” he said.
There won’t be enough shots for the general population until spring, so doses will be rationed at least for the next several months. President-elect Joe Biden pledged earlier this month to have 100 million doses distributed in his first 100 days in office, and his surgeon general nominee said Sunday that it’s still a realistic goal.
But Vivek Murthy told NBC’s “Meet the Press” it’s more realistic to think it may be midsummer or early fall before vaccines are available to the general public, rather than late spring. Murthy said Biden’s team is working toward having the shots available to lower-risk individuals by late spring but doing so requires “everything to go exactly on schedule.”
Meanwhile, Trump’s surgeon general, Jerome Adams, defended the administration’s handling of the Pfizer vaccine Sunday, a day after the Army general charge of getting COVID-19 vaccines across the U.S. apologized Saturday for “miscommunication” with states over the number of doses to be delivered in the early stages of distribution. At least a dozen states reported they would receive a smaller second shipment of the Pfizer vaccine than they had been told previously.
Gen. Gustave Perna told reporters in a telephone briefing that he made mistakes by citing numbers of doses that he believed would be ready. Slaoui said the mistake was assuming vaccines that had been produced were ready for shipment when there was a two-day delay.
“And unless it’s perfectly right, we will not release vaccine doses for usage,” he said. “And, sometimes, there could be small hiccups. There have been none, actually, in manufacturing now. The hiccup was more into the planning.”
But Adams told CBS’ “Face the Nation” that “the numbers are going to go up and down.”
“It absolutely was not poor planning,” he said. “There’s what we plan. There’s what we actually allocate. There’s what’s delivered, and then there’s what’s actually put in people’s arms.”
Adams, who is Black, said he understands that mistrust of the medical community and the vaccine among Blacks “comes from a real place,” the mistreatment of communities of color. He cited the decades-long Tuskegee experiment in Alabama, where Black men with syphilis were not treated so the disease could be studied.
He also said immigrants in the U.S. illegally should not be denied the vaccine because of their legal status because “it’s not ethically right to deny those individuals.”
“I want to reassure people that your information when collected to get your second shot, if you get the Pfizer or Moderna vaccine, will not be used in any way, shape or form to harm you legally,” Adams said. “That is something that I have been assured of.”
Both the Moderna vaccine and the Pfizer-BioNTech shot require two doses several weeks apart. The second dose must be from the same company as the first. Both vaccines appeared safe and strongly protective in large, still unfinished studies.
Hanna reported from Topeka, Kansas. Also contributing was AP Radio correspondent Julie Walker in New York.
In The News
WASHINGTON — A group of U.S. senators led by Sens. Rand Paul, R-Ky., and Lindsey Graham, R-S.C., said they will... Read More
WASHINGTON — A group of U.S. senators led by Sens. Rand Paul, R-Ky., and Lindsey Graham, R-S.C., said they will oppose passage of this year’s defense spending authorization unless the chamber votes to repeal the current COVID-19 vaccine mandate for military personnel. In a letter to... Read More
WASHINGTON — The Biden administration is making $350 million available to increase COVID-19 vaccinations at Health Resources and Services Administration-supported... Read More
WASHINGTON — The Biden administration is making $350 million available to increase COVID-19 vaccinations at Health Resources and Services Administration-supported health facilities. The funding will support health centers administering updated COVID-19 vaccines through mobile, drive-up, walk-up or community-based vaccination events, including working with community-based organizations and... Read More
GENEVA — The World Health Organization has begun using the term “mpox” as the preferred synonym for monkeypox. Both names... Read More
GENEVA — The World Health Organization has begun using the term “mpox” as the preferred synonym for monkeypox. Both names will be used simultaneously for one year while “monkeypox” is phased out, the organization said. According to the WHO, when the current outbreak of monkeypox began... Read More
GENEVA —The statistics are sobering. One in 12 deaths worldwide are caused by some form of injury and/or violence, and... Read More
GENEVA —The statistics are sobering. One in 12 deaths worldwide are caused by some form of injury and/or violence, and when all those deaths are tallied, the outcome shows that traffic accidents, drownings, falls, burns and suicides are taking the lives of some 12,000 people a... Read More
BETHESDA, Md. — A new study has found that high-density lipoprotein cholesterol, the so-called "good cholesterol," may not be as... Read More
BETHESDA, Md. — A new study has found that high-density lipoprotein cholesterol, the so-called "good cholesterol," may not be as effective as scientists once believed in uniformly predicting cardiovascular disease risk among adults of different racial and ethnic backgrounds. In fact, the research, which was supported... Read More
An experimental drug that removes a substance called amyloid — a toxic protein — from the brain appears to slow... Read More
An experimental drug that removes a substance called amyloid — a toxic protein — from the brain appears to slow down Alzheimer's disease. The drug, lecanemab, reduced the rate of cognitive decline by 27% in a study of nearly 1,800 people in the early stages of... Read More